PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 26 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In overweight and obese women, Santa herba extract was administered for 12 weeks to assess impact on body weight and appetite-related parameters [PMID:34255555].
The compound sterubin demonstrated neuroprotection in vitro and prevented decreases in short- and long-term memory in a short-term AD mouse model [PMID:36358569, PMID:32358806].
Eriodictyol reduced cell viability and induced apoptosis in breast cancer cells in vitro [PMID:35580441] and decreased the incidence of polyps and aberrant crypt foci in DMH-induced colon carcinogenesis in rats [PMID:30090535].
Eriodictyon californicum extract had no effect on melanin synthesis, unlike E. angustifolium [PMID:32324292].
Evidence summary
PubMed sources
- 1.PMID: 32324292 (2020) — Eriodictyon angustifolium extract, but not Eriodictyon californicum extract, reduces human hair greying. · International journal of cosmetic science
- 2.PMID: 37473504 (2023) — Chemical characterization and quantitative determination of flavonoids and phenolic acids in yerba santa (Eriodictyon spp.) using UHPLC/DAD/Q-ToF. · Journal of pharmaceutical and biomedical analysis
- 3.PMID: 20058867 (2010) — Identification of bisprenylated benzoic acid derivatives from yerba santa (Eriodictyon ssp.) using sensory-guided fractionation. · Journal of agricultural and food chemistry
- 4.PMID: 38202398 (2023) — Conservation Genetics of the Endangered Lompoc Yerba Santa (Eriodictyon capitatum Eastw., Namaceae), including Phylogenomic Insights into the Evolution of Eriodictyon. · Plants (Basel, Switzerland)
- 5.PMID: 42076034